$180 Million is the total value of Altium Capital Management LP's 91 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 75.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | ASTRIA THERAPEUTICS INC | $17,916,270 | -11.2% | 1,347,088 | -0.6% | 9.94% | -3.0% | |
| New | NOVOCURE LTDcall | $9,712,610 | – | 161,500 | +100.0% | 5.39% | – | |
| ADMA | ADMA BIOLOGICS INC | $9,499,700 | -14.7% | 2,870,000 | 0.0% | 5.27% | -6.8% | |
| BLU | BELLUS HEALTH INC NEW | $8,150,400 | -12.4% | 1,132,000 | 0.0% | 4.52% | -4.3% | |
| KDNY | Sell | CHINOOK THERAPEUTICS INC | $7,060,750 | -30.0% | 305,000 | -20.8% | 3.92% | -23.5% |
| Buy | AMYLYX PHARMACEUTICALS INC | $5,427,900 | +4.9% | 185,000 | +32.1% | 3.01% | +14.6% | |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $5,406,400 | -15.9% | 620,000 | -39.5% | 3.00% | -8.1% |
| ARCELLX INC | $4,621,500 | -0.5% | 150,000 | 0.0% | 2.56% | +8.6% | ||
| AVDL | New | AVADEL PHARMACEUTICALS PLCsponsored adr | $4,580,000 | – | 500,000 | +100.0% | 2.54% | – |
| GKOS | GLAUKOS CORP | $4,559,100 | +14.7% | 91,000 | 0.0% | 2.53% | +25.3% | |
| PEN | New | PENUMBRA INC | $4,459,040 | – | 16,000 | +100.0% | 2.48% | – |
| ATEC | New | ALPHATEC HLDGS INC | $4,212,000 | – | 270,000 | +100.0% | 2.34% | – |
| MYGN | Sell | MYRIAD GENETICS INC | $4,181,400 | +35.9% | 180,000 | -15.1% | 2.32% | +48.5% |
| NEO | Sell | NEOGENOMICS INC | $4,178,400 | +58.7% | 240,000 | -15.8% | 2.32% | +73.3% |
| AKYA | Buy | AKOYA BIOSCIENCES INC | $4,090,000 | +29.5% | 500,000 | +51.5% | 2.27% | +41.4% |
| XTNT | Sell | XTANT MED HLDGS INC | $3,970,069 | -3.7% | 6,227,559 | -0.3% | 2.20% | +5.2% |
| RMD | RESMED INC | $3,722,830 | +5.2% | 17,000 | 0.0% | 2.07% | +15.0% | |
| CTIC | Buy | CTI BIOPHARMA CORP | $3,570,000 | +32.0% | 850,000 | +88.9% | 1.98% | +44.3% |
| Buy | BIOHAVEN LTD | $3,551,600 | +27.9% | 260,000 | +30.0% | 1.97% | +39.7% | |
| RETA | New | REATA PHARMACEUTICALS INCcl a | $3,182,200 | – | 35,000 | +100.0% | 1.77% | – |
| ISEE | Sell | IVERIC BIO INC | $3,162,900 | -22.2% | 130,000 | -31.6% | 1.76% | -15.0% |
| New | MERSANA THERAPEUTICS INCcall | $3,082,911 | – | 750,100 | +100.0% | 1.71% | – | |
| VREX | New | VAREX IMAGING CORP | $3,001,350 | – | 165,000 | +100.0% | 1.67% | – |
| INSP | New | INSPIRE MED SYS INC | $2,925,875 | – | 12,500 | +100.0% | 1.62% | – |
| KRMD | Sell | KORU MEDICAL SYSTEMS INC | $2,890,708 | -5.3% | 685,002 | -19.9% | 1.60% | +3.5% |
| REPL | Sell | REPLIMUNE GROUP INC | $2,613,680 | -39.9% | 148,000 | -7.5% | 1.45% | -34.4% |
| BBIO | New | BRIDGEBIO PHARMA INC | $2,569,900 | – | 155,000 | +100.0% | 1.43% | – |
| MDXG | New | MIMEDX GROUP INC | $2,550,680 | – | 748,000 | +100.0% | 1.42% | – |
| NSTG | New | NANOSTRING TECHNOLOGIES INC | $2,237,321 | – | 225,992 | +100.0% | 1.24% | – |
| VERA | New | VERA THERAPEUTICS INCcl a | $2,219,360 | – | 286,000 | +100.0% | 1.23% | – |
| ILMN | New | ILLUMINA INC | $2,092,950 | – | 9,000 | +100.0% | 1.16% | – |
| New | TG VENTURE ACQUISITION CORP | $2,070,000 | – | 200,000 | +100.0% | 1.15% | – | |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $2,061,240 | -31.0% | 178,000 | -51.2% | 1.14% | -24.6% |
| BLRX | Sell | BIOLINERX LTDsponsored ads | $2,020,916 | +10.4% | 2,279,657 | -26.5% | 1.12% | +20.5% |
| KPTI | New | KARYOPHARM THERAPEUTICS INC | $1,967,488 | – | 505,781 | +100.0% | 1.09% | – |
| CVRX | New | CVRX INC | $1,910,600 | – | 205,000 | +100.0% | 1.06% | – |
| New | VENTYX BIOSCIENCES INC | $1,842,500 | – | 55,000 | +100.0% | 1.02% | – | |
| DYN | New | DYNE THERAPEUTICS INC | $1,785,600 | – | 155,000 | +100.0% | 0.99% | – |
| SILK | New | SILK RD MED INC | $1,760,850 | – | 45,000 | +100.0% | 0.98% | – |
| New | GENEDX HOLDINGS CORP | $1,674,620 | – | 4,588,000 | +100.0% | 0.93% | – | |
| PCVX | VAXCYTE INC | $1,611,640 | -21.8% | 43,000 | 0.0% | 0.90% | -14.6% | |
| CRNX | New | CRINETICS PHARMACEUTICALS IN | $1,606,000 | – | 100,000 | +100.0% | 0.89% | – |
| New | MARINUS PHARMACEUTICALS INC | $1,578,127 | – | 228,714 | +100.0% | 0.88% | – | |
| AULT DISRUPTIVE TECHS CORP | $1,570,500 | +2.1% | 150,000 | 0.0% | 0.87% | +11.7% | ||
| New | WESTERN ACQSTN VENTURES CORP | $1,021,000 | – | 100,000 | +100.0% | 0.57% | – | |
| Sell | PEPPERLIME HEALTH ACQUSTN CO | $1,018,500 | -86.4% | 100,000 | -86.4% | 0.56% | -85.2% | |
| New | THESEUS PHARMACEUTICALS INC | $1,000,012 | – | 112,614 | +100.0% | 0.56% | – | |
| HRMY | New | HARMONY BIOSCIENCES HLDGS IN | $979,500 | – | 30,000 | +100.0% | 0.54% | – |
| FATBW | FAT BRANDS INC*w exp 07/16/202 | $896,650 | +31.2% | 227,000 | 0.0% | 0.50% | +43.5% | |
| COLISEUM ACQUISITION CORP | $872,100 | +2.2% | 85,000 | 0.0% | 0.48% | +11.5% | ||
| GOEDWS | POLISHED COM INC*w exp 06/02/202 | $603,668 | +23.6% | 6,103,824 | 0.0% | 0.34% | +35.1% | |
| NVTA | New | INVITAE CORP | $552,420 | – | 409,200 | +100.0% | 0.31% | – |
| New | GSR II METEORA ACQUISITN COR | $517,500 | – | 50,000 | +100.0% | 0.29% | – | |
| OPY ACQUISITION CORP I | $512,750 | +2.3% | 50,000 | 0.0% | 0.28% | +11.8% | ||
| CLBR | COLOMBIER ACQUISITION CORPcl a | $506,500 | +1.9% | 50,000 | 0.0% | 0.28% | +11.1% | |
| VRNA | Sell | VERONA PHARMA PLCsponsored ads | $502,000 | -91.1% | 25,000 | -88.4% | 0.28% | -90.2% |
| DOUBLEDOWN INTERACTIVE CO LTads | $485,790 | -5.6% | 60,876 | 0.0% | 0.27% | +3.4% | ||
| CSSE | New | CHICKEN SOUP FOR THE SOUL ENcl a | $424,328 | – | 212,164 | +100.0% | 0.24% | – |
| GOED | Sell | POLISHED COM INC | $299,603 | -48.2% | 576,048 | -42.4% | 0.17% | -43.5% |
| WEARABLE DEVICES LTD*w exp 09/14/202 | $193,672 | +13.2% | 1,411,600 | 0.0% | 0.11% | +24.1% | ||
| New | PANBELA THERAPEUTICS INC | $148,280 | – | 335,324 | +100.0% | 0.08% | – | |
| DIRECT DIGITAL HOLDINGS INC*w exp 02/15/202 | $135,000 | -3.8% | 180,000 | 0.0% | 0.08% | +5.6% | ||
| Buy | JEFFS BRANDS LTD*w exp 08/26/202 | $106,058 | +33.7% | 980,770 | +104.0% | 0.06% | +47.5% | |
| New | REVELATION BIOSCIENCES INC | $48,357 | – | 37,198 | +100.0% | 0.03% | – | |
| CINGULATE INC*w exp 12/10/202 | $46,197 | -28.7% | 270,000 | 0.0% | 0.03% | -21.2% | ||
| Sell | INNOVATIVE EYEWEAR INC*w exp 08/16/202 | $44,768 | +144.0% | 122,400 | -18.4% | 0.02% | +177.8% | |
| BRUUSH ORAL CARE INC*w exp 08/03/202 | $43,269 | +121.4% | 360,579 | 0.0% | 0.02% | +140.0% | ||
| NEXGEL INC*w exp 12/01/202 | $34,875 | +3.3% | 225,000 | 0.0% | 0.02% | +11.8% | ||
| PEPPERLIME HEALTH ACQUSTN CO*w exp 10/01/202 | $34,949 | +45.2% | 367,500 | 0.0% | 0.02% | +58.3% | ||
| HARBOR CUSTOM DEVELOPMENT IN*w exp 10/07/202 | $32,435 | -16.7% | 650,000 | 0.0% | 0.02% | -10.0% | ||
| NLSPW | NLS PHARMACEUTICS LTD*w exp 02/02/202 | $30,000 | -21.1% | 200,000 | 0.0% | 0.02% | -10.5% | |
| ONFOLIO HOLDINGS INC*w exp 01/02/202 | $28,090 | -41.5% | 200,000 | 0.0% | 0.02% | -33.3% | ||
| PROSOMNUS INC*w exp 04/20/202 | $23,700 | +101.0% | 150,000 | 0.0% | 0.01% | +116.7% | ||
| CEA INDUSTRIES INC*w exp 02/11/202 | $19,825 | -11.9% | 250,000 | 0.0% | 0.01% | 0.0% | ||
| ZEVWS | LIGHTNING EMOTORS INC*w exp 05/18/202 | $16,630 | -34.3% | 652,173 | 0.0% | 0.01% | -30.8% | |
| HCDIW | HARBOR CUSTOM DEVELOPMENT IN*w exp 05/09/202 | $14,460 | -16.9% | 600,000 | 0.0% | 0.01% | -11.1% | |
| DIGITAL HEALTH ACQUISITION C*w exp 11/02/202 | $12,750 | -14.1% | 150,000 | 0.0% | 0.01% | -12.5% | ||
| NEXALIN TECHNOLOGY INC*w exp 09/15/202 | $9,975 | -52.5% | 105,000 | 0.0% | 0.01% | -45.5% | ||
| SELINA HOSPITALITY PLC*w exp 10/27/202 | $10,144 | +25.0% | 101,439 | 0.0% | 0.01% | +50.0% | ||
| SURROZEN INC*w exp 08/01/203 | $8,223 | +17.1% | 82,233 | 0.0% | 0.01% | +25.0% | ||
| New | MURPHY CANYON ACQUISITION CO*w exp 01/25/202 | $9,000 | – | 100,000 | +100.0% | 0.01% | – | |
| New | WESTERN ACQSTN VENTURES CORP*w exp 09/01/202 | $8,900 | – | 100,000 | +100.0% | 0.01% | – | |
| New | TG VENTURE ACQUISITION CORP*w exp 08/15/202 | $9,000 | – | 200,000 | +100.0% | 0.01% | – | |
| OPY ACQUISITION CORP I*w exp 09/22/202 | $7,665 | +137.7% | 50,000 | 0.0% | 0.00% | +100.0% | ||
| EUCRW | EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202 | $4,820 | -35.0% | 133,333 | 0.0% | 0.00% | -25.0% | |
| CHAVANT CAPITAL ACQUISITN CO*w exp 99/99/999 | $4,710 | -78.3% | 150,000 | 0.0% | 0.00% | -72.7% | ||
| CLBRWS | COLOMBIER ACQUISITION CORP*w exp 99/99/999 | $3,605 | +151.6% | 16,666 | 0.0% | 0.00% | +100.0% | |
| COLISEUM ACQUISITION CORP*w exp 08/22/202 | $4,108 | +102.8% | 28,333 | 0.0% | 0.00% | +100.0% | ||
| TC BIOPHARM HOLDINGS PLC*w exp 02/08/202 | $1,880 | +11.6% | 18,823 | 0.0% | 0.00% | 0.0% | ||
| New | GSR II METEORA ACQUISITN COR*w exp 02/24/202 | $2,000 | – | 50,000 | +100.0% | 0.00% | – | |
| RELATIVITY ACQUISITION CORP*w exp 12/15/202 | $0 | -100.0% | 100,000 | 0.0% | 0.00% | -100.0% | ||
| Exit | TILRAY BRANDS INCcall | $0 | – | -7,600 | -100.0% | -0.01% | – | |
| MBTCR | Exit | NOCTURNE ACQUISITION CORPright 12/26/2025 | $0 | – | -500,000 | -100.0% | -0.02% | – |
| HSAQ | Exit | HEALTH SCIENCES ACQ CORP 2 | $0 | – | -10,000 | -100.0% | -0.05% | – |
| Exit | ASTRIA THERAPEUTICS INCcall | $0 | – | -7,700 | -100.0% | -0.06% | – | |
| ZEV | Exit | LIGHTNING EMOTORS INC | $0 | – | -581,852 | -100.0% | -0.11% | – |
| TRKA | Exit | TROIKA MEDIA GROUP INC | $0 | – | -2,672,640 | -100.0% | -0.16% | – |
| Exit | ABEONA THERAPEUTICS INC | $0 | – | -108,696 | -100.0% | -0.17% | – | |
| KURA | Exit | KURA ONCOLOGY INC | $0 | – | -28,198 | -100.0% | -0.18% | – |
| Exit | MEDIWOUND LTD | $0 | – | -27,286 | -100.0% | -0.19% | – | |
| Exit | GSR II METEORA ACQUISITN CORunit 02/24/2027 | $0 | – | -50,000 | -100.0% | -0.27% | – | |
| Exit | PEPGEN INC | $0 | – | -40,000 | -100.0% | -0.27% | – | |
| Exit | RXSIGHT INC | $0 | – | -50,586 | -100.0% | -0.33% | – | |
| TERN | Exit | TERNS PHARMACEUTICALS INC | $0 | – | -70,000 | -100.0% | -0.36% | – |
| HYRE | Exit | HYRECAR INC | $0 | – | -1,688,120 | -100.0% | -0.36% | – |
| Exit | SOMALOGIC INC | $0 | – | -310,000 | -100.0% | -0.40% | – | |
| TSHA | Exit | TAYSHA GENE THERAPIES INC | $0 | – | -359,051 | -100.0% | -0.41% | – |
| ARYD | Exit | ARYA SCIENCES ACQU CORP IVcl a | $0 | – | -100,000 | -100.0% | -0.51% | – |
| Exit | MURPHY CANYON ACQUISITION COunit 01/25/2027 | $0 | – | -100,000 | -100.0% | -0.52% | – | |
| Exit | WESTERN ACQSTN VENTURES CORPunit 09/01/2026 | $0 | – | -100,000 | -100.0% | -0.56% | – | |
| Exit | SYROS PHARMACEUTICALS INC | $0 | – | -315,070 | -100.0% | -0.58% | – | |
| Exit | TG THERAPEUTICS INCcall | $0 | – | -100,000 | -100.0% | -0.60% | – | |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.97% | – |
| PLRX | Exit | PLIANT THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.98% | – |
| Exit | TG VENTURE ACQUISITION CORPunit 08/15/2028 | $0 | – | -200,000 | -100.0% | -1.04% | – | |
| COLL | Exit | COLLEGIUM PHARMACEUTICAL INC | $0 | – | -90,000 | -100.0% | -1.06% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -17,500 | -100.0% | -1.06% | – |
| CARA | Exit | CARA THERAPEUTICS INC | $0 | – | -195,960 | -100.0% | -1.07% | – |
| SIBN | Exit | SI-BONE INC | $0 | – | -195,000 | -100.0% | -1.35% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -76,000 | -100.0% | -1.53% | – |
| QTRX | Exit | QUANTERIX CORP | $0 | – | -224,800 | -100.0% | -1.58% | – |
| OTLK | Exit | OUTLOOK THERAPEUTICS INC | $0 | – | -3,327,404 | -100.0% | -1.83% | – |
| ESPR | Exit | ESPERION THERAPEUTICS INC NE | $0 | – | -620,000 | -100.0% | -1.96% | – |
| TNDM | Exit | TANDEM DIABETES CARE INC | $0 | – | -90,000 | -100.0% | -2.06% | – |
| KRTX | Exit | KARUNA THERAPEUTICS INC | $0 | – | -22,000 | -100.0% | -2.20% | – |
| RYTM | Exit | RHYTHM PHARMACEUTICALS INC | $0 | – | -170,000 | -100.0% | -2.52% | – |
| ITCI | Exit | INTRA-CELLULAR THERAPIES INC | $0 | – | -100,000 | -100.0% | -2.69% | – |
| AKRO | Exit | AKERO THERAPEUTICS INC | $0 | – | -125,000 | -100.0% | -3.48% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FAT BRANDS INC | 12 | Q3 2023 | 0.6% |
| CHINOOK THERAPEUTICS INC | 11 | Q2 2023 | 8.9% |
| BELLUS HEALTH INC NEW | 10 | Q1 2023 | 4.7% |
| XTANT MED HLDGS INC | 10 | Q3 2023 | 5.1% |
| IVERIC BIO INC | 10 | Q1 2023 | 2.3% |
| MYRIAD GENETICS INC | 10 | Q1 2023 | 2.3% |
| HARBOR CUSTOM DEVELOPMENT IN | 10 | Q3 2023 | 0.1% |
| CRINETICS PHARMACEUTICALS IN | 9 | Q3 2023 | 4.1% |
| CTI BIOPHARMA CORP | 9 | Q1 2023 | 2.6% |
| POLISHED COM INC | 9 | Q2 2023 | 3.4% |
View Altium Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Marpai, Inc. | April 26, 2023 | 1,805,327 | 6.2% |
| Astria Therapeutics, Inc. | February 14, 2023 | 1,355,372 | 5.0% |
| HyreCar Inc. | February 14, 2023 | 1,688,120 | 5.6% |
| Muscle Maker, Inc. | February 14, 2023 | 2,888,085 | 5.0% |
| NeuroBo Pharmaceuticals, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| PALISADE BIO, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| 1847 Goedeker Inc. | February 14, 2022 | 6,103,824 | 5.0% |
| BioRestorative Therapies, Inc. | February 14, 2022 | 200,000 | 5.0% |
| BriaCell Therapeutics Corp. | February 14, 2022 | 900,000 | 4.7% |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | February 14, 2022 | 363,000 | 5.0% |
View Altium Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-02-21 |
| SC 13G | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View Altium Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.